Nykode Therapeutics AS announced that its Chief Executive Officer, Michael Engsig, and Chief Innovation and Strategy Officer, Agnete Fredriksen, will present and provide a corporate update at the SVB Leerink 2022 Global Healthcare Conference on February 18, 2022 at 2:00 p.m. CET/ 8:00 a.m. EST and are available for 1:1 investor meetings.
February 14, 2022
· 2 min read